首页> 美国卫生研究院文献>Elsevier Sponsored Documents >Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre parallel group randomised controlled trial

【2h】

Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre parallel group randomised controlled trial

机译：肺炎球菌结合疫苗13在英国婴儿中以一剂和一剂加强剂量（1 + 1）的剂量提供而两剂和一剂加强剂量（2 + 1）的递送：多中心平行组随机对照试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Elsevier Sponsored Documents
作者
David Goldblatt; Jo Southern; Nick J Andrews; Polly Burbidge; Jo Partington; Lucy Roalfe; Marta Valente Pinto; Vasilli Thalasselis; Emma Plested; Hayley Richardson; Matthew D Snape; Elizabeth Miller;
展开▼
作者单位

展开▼
年(卷),期 -1(18),2
年度 -1
页码 171–179
总页数 9
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1?+?1) compared with two primary doses and a booster (2?+?1) in UK infants: a multicentre, parallel group randomised controlled trial [J] . David Goldblatt, Jo Southern, Nick J Andrews, The Lancet infectious diseases . 2018,第2期

机译：肺炎球菌缀合物疫苗13作为一个初级和一个增强剂量（1？+ 1），与英国婴儿的两个主要剂量和增压器（2？+？1）相比：多期，并行组随机对照试验
2. Comparison of two-dose priming plus 9-month booster with a standard three-dose priming schedule for a ten-valent pneumococcal conjugate vaccine in Nepalese infants: a randomised, controlled, open-label, non-inferiority trial [J] . Hamaluba Mainga, Kandasamy Rama, Upreti Shyam R., The Lancet infectious diseases . 2015,第4期

机译：在尼泊尔婴儿中对10价肺炎球菌结合疫苗进行两次剂量初次加9个月加强免疫与标准三次剂量初次接种的比较：一项随机，对照，开放标签，非劣效性试验
3. Comparison of anti-capsular antibody quantity and functionality in children after different primary dose and booster schedules of 13 valent-pneumococcal conjugate vaccine [J] . Vaccine . 2020,第28期

机译：不同初级剂量和13例肺炎球菌缀合物疫苗后儿童抗囊抗体抗体量和功能的比较
4. Protocol: 10-Valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children: study protocol for a randomised controlled trial [O] . Victor M Oguoma, Nicole Wilson, Kim Mulholland, 2020

机译：方案：10价肺炎球菌不可分型流感嗜血杆菌D结合疫苗（PHiD-CV10）与13价肺炎球菌结合疫苗（PCV13）作为加强剂量以扩大和加强澳大利亚土著儿童的中耳炎保护（PREVIX_BOOST）：一项随机对照试验的研究方案
5. Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trial [O] . Goldblatt, D, Southern, J, Andrews, NJ, 2017

机译：肺炎球菌结合疫苗13在英国婴儿中以一剂和一剂加强剂量（1 +1）分发，而两剂和一剂加强剂量（2 +1）分发：一项多中心，平行组随机对照试验

Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre parallel group randomised controlled trial

著录项

相似文献

相关主题

期刊订阅